Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 3, 2003, Pages 232-240

  Pedersen Bjergaard, Ulrik ^a   Pramming, Stig ^b   Thorsteinsson, Birger ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Awareness; Counterregulation; Hypoglycaemia; Type 1 diabetes mellitus; Unawareness

Indexed keywords

INSULIN;

ADULT; ARTICLE; AWARENESS; CLASSIFICATION; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGE OF ONSET; AWARENESS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; MALE; MEMORY; MIDDLE AGED; OUTPATIENTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECORDS; REGRESSION ANALYSIS;

EID: 0038619056     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.377     Document Type: Article

References (24)

1. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991; 8: 217-222.
2. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993; 10: 238-245.
3. Mühlhauser I, Overmann H, Bender R, Bott U, Berger M. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes - a prospective population based study. Diabetologia 1998; 41: 1274-1282.
4. ter Braak EWMT, Appelman AMMF, van de Laak MF, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000; 23: 1467-1471.
5. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 1990; 7: 711-717.
6. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet 2001; 357: 1248-1253.
7. Clarke WL, Gonder-Frederick L, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycaemia in IDDM adults: a prospective study of hypoglycaemic frequency and associated symptoms. Diabetes Care 1995; 18: 517-522.
8. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycaemia in patients with type 1 diabetes with impaired awareness of hypoglycaemia. Diabetes Care 1994; 17: 697-703.
9. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 1997; 46: 271-286.
10. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 2003; 46: 89-96.
11. Deary IJ, Hepburn DA, MacLeod EM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factors analysis. Diabetologia 1993; 36: 771-777.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-310.
13. Gold AE, Frier BM, MacLeod KM, Deary IJ. A structural equation model for predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus. Diabet Med 1997; 14: 309-315.
14. Heller SR, Herbert M, Macdonald IA, Tattersall RB. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet 1987; ii: 359-363.
15. Towler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791-1798.
16. Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE. Reduced β-adrenergic sensitivity in patients with type 1 diabetes and hypoglycaemia unawareness. Diabetes Care 1998; 21: 1939-1943.
17. Mokan M, Mitrakou A, Veneman T, et al. Hypoglycemia. unawareness in IDDM. Diabetes Care 1994; 17: 1397-1403.
18. Fritsche A, Stefan N, Häring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001; 134: 729-736.
19. Hepburn DA, Patrick AW, Brash HM, Thomson I, Frier BM. Hypoglycaemia unawareness in type 1 diabetes: a lower plasma glucose is required to stimulate sympatho-adrenal activation. Diabet Med 1991; 8: 934-945.
20. Jørgensen HV, Pedersen-Bjergaard U, Rasmussen ÅK, Borch-Johnsen K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives to patients with type 1 diabetes. Diabetes Care 2003; 26: in press.
21. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993; 42: 1683-1689.
22. Cranston I, Lomas J, Maran A, Macdonald IA, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344: 283-287.
23. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycaemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994; 43: 1426-1434.
24. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 1995; 38: 1412-1418.